TNFSF4 and neoplasm: Intratumoral delivery of the armed oncolytic virus encoding OX40L and IL12 could transform tumor cells into artificial antigen-presenting cells in situ to unleash the full potential of adoptive cell therapy with tumor-infiltrating T cells.